Tenax Therapeutics, Inc. · NASDAQ:TENX
Venrock Healthcare Capital Partners III, L.P. reported a 9.90% stake in Tenax Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Venrock Healthcare Capital Partners III, L.P. reported a 9.90% stake in Tenax Therapeutics, Inc., 1,955,105 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 1,955,105
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. | 9.90% | 1,955,105 |
| VHCP Co-Investment Holdings III, LLC | 9.90% | 1,955,105 |
| Venrock Healthcare Capital Partners EG, L.P. | 9.90% | 1,955,105 |
| VHCP Management III, LLC | 9.90% | 1,955,105 |
| VHCP Management EG, LLC | 9.90% | 1,955,105 |
| Nimish Shah | 9.90% | 1,955,105 |
| Bong Y. Koh | 9.90% | 1,955,105 |
Source
Related
- Tenax Therapeutics, Inc.
- Venrock Healthcare Capital Partners III, L.P.
- Tenax Therapeutics, Inc. shareholders
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Feb 17, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Nov 14, 2025
- Form 4 · ADAR1 Capital Management, LLC · Oct 21, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 15, 2026
- Schedule 13G/A · Sphera Funds Management LTD. · Oct 13, 2026
- Schedule 13G/A · Dellora Investments LP · Oct 9, 2026
- Form 4 · Doogan Declan · Sep 17, 2026